Unlocking the Next Generation of Reporting and Analytics for Drug Safety Intelligence
The Future of Drug Safety Intelligence The future of safety ...

Madrid, Spain
10 – 11 Feb 2026
Operationalizing AI: Turning proven AI use cases into everyday practice across life sciences.

SVP, Head of Regulatory Affairs and PV Operations
Astellas


SVP, Worldwide Patient Safety Officer
Bristol Myers Squibb

The Future of Drug Safety Intelligence The future of safety ...
ArisGlobal Announces the Launch of LifeSphere Clarity As a pharmacovigilance ...
Every person who wants to participate in clinical research should ...
There’s no doubt that the pharmaceutical industry is well into ...
Managing your Trial Master File (TMF) is a necessary, and ...
Identification of Medical Products (IDMP) has been harmonizing data globally ...
The coronavirus pandemic ushered in a new era of public ...
Learn why Breakthrough is more than just an event but a summit for thought leaders in health and life sciences to discuss today and the future.
Digital Impact on the Drug Safety Space Digital transformation, automation, ...
The DIA Medical Affairs and Scientific Communications (MASC) Forum is ...
ArisGlobal is a pivotal partner in the life sciences industry, specializing in solutions that drive drug development, safety monitoring, and regulatory compliance. We collaborate with more than 220 global life sciences companies, CROs, and government health authorities, including leading biopharmaceutical firms and regulatory bodies such as FDA, Health Canada, and NMPA.
Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan and China.
Quick Links
© 2024 ArisGlobal – All Rights Reserved